Registration overview of medical devices

Understand the evaluation routes, fees and turn-around-times applicable when you register your medical device.

Evaluation routes

Each device registration is done via a specific evaluation route. The evaluation route for your device depends on:

  • Risk classification of your device
  • Number of prior approvals given by our overseas reference regulatory agencies
  • Duration of safe marketing history for your device

The evaluation route of your device will determine the turn-around-time (TAT), fees and documents required for registration.

Class A registration

Class A medical devices are exempted from product registration. However, you will need to complete the Class A Exemption List in MEDICS during your dealer's licence application.

Class B, C and D registration

Registration requirements

Registration requirements

Refer to the table below for an overview of the evaluation routes for Class B, C and D medical devices.

A medical device without prior approval from any of our overseas reference regulatory agencies must undergo a full evaluation.

 

Evaluation routes Conditions

Full

Full (Priority Review Scheme)

No prior approval by any of our overseas reference regulatory agencies

Abridged

Approval from at least one of our overseas reference regulatory agencies

Expedited routes:

  • Class C registration (ECR)
  • Class D registration (EDR)

ECR-1:

  • Approval from at least one of our overseas reference regulatory agencies
  • Marketed for at least three years in Singapore, or in the respective agencies' jurisdictions
  • No safety issues globally
  • No prior rejection/withdrawal by us or any overseas reference regulatory agencies

ECR-2/EDR:

  • Approval from at least two of our overseas reference regulatory agencies
  • No prior rejection/withdrawal by us or any overseas reference regulatory agencies
Immediate Class B Registration (IBR)

Condition 1:

  • Approval from at least one of our overseas reference regulatory agencies
  • Marketed for at least three years in Singapore, or in the respective agencies' jurisdictions
  • No safety issues globally
  • No prior rejection/withdrawal by us or any overseas reference regulatory agencies

Condition 2:

  • Approval from at least two of our overseas reference regulatory agencies
  • No safety issues globally
  • No prior rejection/withdrawal by us or any overseas reference regulatory agencies
Immediate routes, solely for standalone medical mobile applications:
  • Class B
  • Class C
  • Approval from at least one of our overseas reference regulatory agencies
  • No safety issues globally
  • No prior rejection/withdrawal by us or any overseas reference regulatory agencies

Devices not qualified for expedited routes

Class C devices

The following medical devices cannot take the expedited Class C (ECR) route. These devices can only be registered via the full or abridged routes.

  • Hip, knee and shoulder joint replacement non-bioactive implants (e.g. non-bioactive metal/polymer implants)

Class D devices

The following medical devices cannot take the expedited Class D (EDR) route. These devices can only be registered via the full or abridged routes.

  • Active implantable devices (e.g. pacemakers, neurostimulators)
  • Implantable devices in direct contact with the central circulatory system or central nervous system
  • Hip, knee and shoulder joint replacement (e.g. bioactive implants)
  • Devices with a registrable drug in a secondary role
  • IVD assays intended for HIV testing (screening and diagnosis) and blood/tissue donor compatibility testing

Overseas reference regulatory agencies

The approvals that qualify for the abridged, expedited and immediate evaluation routes are listed in the following table. These approvals must be on the same medical device labelled use that is intended for the Singapore market.

Overseas reference regulatory agencies Recognised approvals

Australia Therapeutic Goods Administration (TGA)

  • Device Registration Licence
European Union Notified Bodies (EU NB) For Class B
Via EC certificates issued according to:
  • Directive 93/42/EEC Annex II section 3 or Annex V for Class IIA devices
  • Directive 98/79/EC Annex IV or Annex V with Annex VII for List B and self-testing IVDs
For Class C and D
Via EC certificates issued according to:
  • Directive 93/42/EEC Annex II section 3 or Annex III with Annex V for Class IIb
  • Directive 93/42/EEC Annex II section 3 and 4 for Class III
  • Directive 90/385/EEC Annex II section 3 and 4 for Active Implantable Medical Devices
  • Directive 98/79/EC Annex IV including sections 4 and 6 for List A IVDs
  • Directive 98/79/EC Annex IV or Annex V with Annex VII for List B and self-testing IVDs
Health Canada (HC)
  • Device Registration Licence
Japan Ministry of Health, Labour and Welfare (MHLW)
  • Pre-market certification (Ninsho) from a Japanese registered certification body
  • Pre-market approval (Shonin) from MHLW
US Food and Drug Administration (US FDA)
  • 510K clearance
  • Premarket approval (PMA)

Priority Review Scheme

The Priority Review Scheme provides the option for you to gain faster device registration and market entry for medical devices that are submitted to us through the full evaluation route.

Fees and turn-around-time

During the evaluation process, we will verify the information and supporting documents you submit, and will contact you if we need additional information from you via an Input Request (IR). Your device registration may be delayed if we do not receive all the necessary information in time.

Refer to medical device fees and turn-around-time for more information.

Share